Product Reports Resources Pricing Login Book a demo

Injective

Fintech · New York City, United States · Founded 2018

Develops a fully-decentralized exchange protocol that eliminates front-running and allows for trustless liquidity sharing

Valuation $1–2.5B
Revenue $10–50M
Headcount 100–500
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Injective and the history behind them.
Power Law Unicorn$1–10B valuation tier Colt$25–100M revenue

Talent graph

Injective's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

8 investors on Injective's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 7 investors entered at this stage
BoxOne Ventures
Innovating Capital
Krypital Group
BitScale
The Cabin Capital
Pantera Capital
QCP Soteria
Series B+ 1 investor entered at this stage
Jump Crypto

Ownership

Who owns Injective

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

56.5% Founders
  • Pantera Capital 12.5%

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where Injective has talent and traffic

Workforce by country
30 countries with
team presence
🇺🇸 United States23.9%
🇳🇬 Nigeria9.4%
🇮🇳 India5.7%
🇸🇬 Singapore4.6%
🇮🇩 Indonesia4.4%
Top 5 of 30 shown
Web traffic by country
8.6K monthly visits
across markets
🇮🇩 Indonesia100%
Top 1 markets shown

Capital deployed

Injective's 3 investments and acquisitions.

Every disclosed deal where Injective appeared as a backer or acquirer, 2021–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Injective's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Injective's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Injective

        An AI-synthesized read of the highest-engagement posts about Injective on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Injective on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles